Interesting that perlegen has raised $130 mill over the past 3+ years.....and this is in addition to any seed capital provided by Affy plus any proceeds from the numerous collaborations they've had with big pharma to date.
Just how expensive can their whole genome scan be??
And as Ming pointed out, no products to date.
In comparison, dnap looks to be quite efficient....
News 
Market Data 
Discover 
